The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Low testosterone or testosterone deficiency, also known as hypogonadism, is a condition in which patients develop symptoms.
The Fox News Health Newsletter brings you trending and important stories about health care, drug developments, mental health ...
According to the NYPD, a 58-year-old cab driver suffered a medical episode when he drove onto the sidewalk at West 34th Street and Sixth Avenue. A man accused of attempting to assassinate ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...